#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3616010	B	Transactivation of XBP1 (unknown origin) transfected in rat IEC-6 cells at 10 uM after 48 hrs by dual luciferase reporter gene assay	Homo sapiens	28	ALA3611992	cell-based format	Scientific Literature
2.	ALA3616011	B	Transactivation of XBP1 (unknown origin) transfected in rat IEC-6 cells at 10 uM after 48 hrs by dual luciferase reporter gene assay relative to con 2	Homo sapiens	2	ALA3611992	cell-based format	Scientific Literature
3.	ALA3616012	B	Transactivation of XBP1 (unknown origin) transfected in rat IEC-6 cells after 48 hrs by dual luciferase reporter gene assay	Homo sapiens	3	ALA3611992	cell-based format	Scientific Literature
4.	ALA3616016	T	Toxicity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as change in body weight at 200 mg/kg, po qd (Rvb = -15.3%)	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
5.	ALA3616017	T	Toxicity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as change in body weight at 100 mg/kg, po qd (Rvb = -15.3%)	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
6.	ALA3616018	T	Toxicity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as change in body weight at 50 mg/kg, po qd (Rvb = -15.3%)	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
7.	ALA3616020	F	Anti-ulcerative colitis activity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as inhibition rate of disease activity index at 200 mg/kg, po qd measured on day 8 relative to control	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
8.	ALA3616021	F	Anti-ulcerative colitis activity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as inhibition rate of disease activity index at 100 mg/kg, po qd measured on day 8 relative to control	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
9.	ALA3616022	F	Anti-ulcerative colitis activity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as inhibition rate of disease activity index at 50 mg/kg, po qd measured on day 8 relative to control	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
10.	ALA3616136	F	Anti-ulcerative colitis activity in po dosed DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as inhibition rate of disease activity index administered as qd measured on day 8	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
11.	ALA3616139	F	Anti-ulcerative colitis activity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as improvement in colon contracture at 200 mg/kg, po qd measured on day 8 (Rvb = 41.8%)	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
12.	ALA3616140	F	Anti-ulcerative colitis activity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as improvement in colon contracture at 100 mg/kg, po qd measured on day 8 (Rvb = 41.8%)	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature
13.	ALA3616141	F	Anti-ulcerative colitis activity in DSS-induced acute C57Bl/6J mouse ulcerative colitis model assessed as improvement in colon contracture at 50 mg/kg, po qd measured on day 8 (Rvb = 41.8%)	Mus musculus	2	ALA3611992	organism-based format	Scientific Literature